X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CLNNW

Closed

Clene Inc

0.0314
+0.0094 (+42.73%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.022
Day's Range: 0.0222 - 0.032
Send
When Written:
 
0.09
Clene Inc is a clinical-stage biopharmaceutical company that is focused on the development of novel therapeutics for the treatment of neurodegenerative diseases. The company's lead drug candidate, CNM-Au8, is a nanocrystalline gold particle that has been shown to have neuroprotective and neurorestorative properties in preclinical studies.

Clene Inc was founded in 2013 and is headquartered in Salt Lake City, Utah. The company's mission is to develop innovative therapies that can improve the lives of patients suffering from debilitating neurological conditions such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

In addition to CNM-Au8, Clene Inc is also developing several other drug candidates that target different aspects of neurodegeneration. The company is backed by a team of experienced scientists and executives with a proven track record of success in the biopharmaceutical industry.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X